MiR-942 directly binds to c-Myc and upregulates Wnt/β-catenin signaling activity in esophageal squamous cell carcinoma (ESCC), suggesting that miR-942 is an effective therapeutic target [57]. This evidence concerns the gene MYC and esophageal squamous cell carcinoma.